Regulatory mechanisms on drug spendings in Czech repubulic

Obsah

1. Regulatory mechanisms on drug spendings in Czech repubulic
2. Contents
3. Overview of the Czech healthcare system
4. Year 2000 - new challenges
5. Healthcare expenditure in CR from health insurance funds (mil. EUR)
6. Drug spendings in CR (thousands of EUR)
7. General Insurance Company spendings on health care
8. Spendings on drugs in CR 1996
9. Top 10 drug groups spent by healh insurance funds on prescriptions (mil. EUR)
10. Antipsychotics I: minor change in DDD... thousands of DDD/year
11. Antipsychotics II: …can make substantial change in spendings thousands of EUR/year
12. Pricing
13. Reimbursement
14. Problems with the law
15. Proposed changes in the law
16. Example of proposed merge of drug groups
17. Decree: Principals of stating the reimbursement level
18. Drug categorisation committee
19. Members od categorisation committee
20. Ways of administration
21. VZP issues the drug-list:
22. Regulation provided by patients
23. Doctor´s regulation: Drug limists I.
24. Doctor´s regulation: Drug limists II.
25. Doctor´s regulation: Informations
26. More sofisticated regulations: Near future?
27. Choice of methods

Autor: MUDr. Michal Prokeš

Elektronická pošta: michal.prokes@mzcr.cz

Domovská stránka: http://www.farmakologie.net